![Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley](https://onlinelibrary.wiley.com/cms/asset/e5de7842-12d0-4771-abac-e5bbc7ee40d7/jimd12338-fig-0003-m.jpg)
Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley
![Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile](https://www.researchgate.net/publication/349464306/figure/fig2/AS:995748858560512@1614416436462/a-The-25-most-frequently-recorded-diseases-in-the-registry-b-Distribution-of-the_Q320.jpg)
Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile
Školitelský posudek na diplomovou práci Bc. Terezy Bělinové nazvané „Sledování vlivu křemíkových nanočástic na l
![Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley](https://onlinelibrary.wiley.com/cms/asset/edbc47d4-db5d-48ea-8ea8-841fc940ee42/jimd.v44.3.cover.jpg?trick=1678057552270)
Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley
Homocystinuria - HCU Network Australia - On Tuesday 30 November, HCU Network Australia together with E-HOD will host the 4th International Homocystinurias Patient Expert Meeting. Registration for the virtual event is free.
![Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile](https://www.researchgate.net/profile/Viktor-Kozich/publication/349650659/figure/tbl1/AS:996540038512642@1614605068483/Characteristics-information-products-in-different-European-countries-1_Q320.jpg)
Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile
Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemic
![Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley](https://onlinelibrary.wiley.com/cms/asset/9a842eab-ed2a-46b5-ba6d-8482395716a6/jimd12338-fig-0002-m.jpg)
Cystathionine β‐synthase deficiency in the E‐HOD registry‐part I: pyridoxine responsiveness as a determinant of biochemical and clinical phenotype at diagnosis - Kožich - 2021 - Journal of Inherited Metabolic Disease - Wiley
Prof. Viktor Kožich, M.D., Ph.D. Professor Kožich graduated from the School of General Medicine, Charles University
![Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile](https://c5.rgstatic.net/m/437738464651637/images/template/default/profile/profile_default_l.jpg)
Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile
![Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile Viktor KOZICH | Professor (Full) | Professor, MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pediatrics and Adolescent Medicine (1. LF) | Research profile](https://www.researchgate.net/profile/Urh-Groselj/publication/349836055/figure/fig1/AS:998299779747840@1615024623022/Map-of-the-International-Society-for-Neonatal-ISNS-European-region-colour-coded-by-the_Q320.jpg)